Mounjaro Injection Pen – 5 mg (Tirzepatide)
Injection Pen – 5 mg Mounjaro (Tirzepatide) is a once-weekly injectable treatment designed to support healthy blood sugar regulation and weight-management goals. Each pre-filled pen delivers a precise dose of tirzepatide, an advanced dual-action incretin therapy that targets both GIP and GLP-1 receptors to improve insulin response, regulate appetite, and support metabolic balance.
The 5 mg dose is commonly introduced after the initial 2.5 mg starting phase, allowing patients to continue treatment with an increased therapeutic effect while maintaining good tolerability. By slowing digestion and influencing appetite signals, tirzepatide helps individuals feel fuller for longer periods, which may support reduced calorie intake and gradual weight loss.
Designed for convenience, the pre-filled injection pen enables simple once-weekly administration and can be used at home following appropriate medical guidance. When combined with a healthy diet and regular physical activity, this treatment may help support long-term metabolic health and improved glycemic control.
Price range: $699.00 through $2,499.00
* The information on this page is a summary and is not intended to cover all available information about this medication. It does not cover all possible uses, directions, precautions, drug interactions or adverse effects and is not a substitute for the expertise and judgement of your healthcare professional.
Everything You Need To Know
Injection Pen – 5 mg Mounjaro (Tirzepatide) contains tirzepatide, a modern medication developed to help regulate blood sugar levels and assist with weight management through a unique dual-hormone mechanism. Tirzepatide activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, two key hormones involved in glucose metabolism and appetite regulation.
By stimulating insulin release when blood sugar levels are elevated and reducing glucose production by the liver, tirzepatide helps improve glycemic stability. At the same time, it slows gastric emptying, which helps prolong the feeling of fullness after meals and may reduce overall calorie intake.
The 5 mg dose is typically used as the first therapeutic step after the starting dose, helping patients gradually increase treatment intensity while allowing the body to adapt to the medication. Each pen is pre-filled for convenient subcutaneous injection once per week.
Improved blood sugar management
Tirzepatide helps regulate glucose levels by increasing insulin secretion and reducing glucose production in the liver.
Supports appetite control
The medication slows digestion and influences hunger signals, helping users feel satisfied for longer after meals.
Gradual treatment progression
The 5 mg dose represents the next step after the initial starting dose, supporting a gradual and well-tolerated treatment plan.
Dual-hormone metabolic support
By targeting both GLP-1 and GIP receptors, tirzepatide offers a broader metabolic effect compared with single-pathway therapies.
Convenient once-weekly dosing
The pre-filled injection pen allows for easy and consistent weekly administration.
Injection Pen – 5 mg Mounjaro (Tirzepatide) is administered as a subcutaneous injection once per week.
General usage guidelines:
Inject once weekly on the same day each week.
The injection may be administered with or without food.
Recommended injection sites include the abdomen, thigh, or upper arm.
Rotate injection sites between doses to reduce irritation.
Follow the dosing schedule recommended by your healthcare provider.
The 5 mg dose is typically prescribed after an initial treatment period with the 2.5 mg dose, allowing patients to gradually increase therapy while minimizing potential side effects.
For best results, treatment should be combined with balanced nutrition, portion control, and regular physical activity.
Injection Pen – 5 mg Mounjaro (Tirzepatide) should be used under the supervision of a qualified healthcare professional.
Important precautions include:
Common side effects may include nausea, vomiting, diarrhea, constipation, or reduced appetite.
Inform your healthcare provider about any existing medical conditions before starting treatment.
Do not use if you are allergic to tirzepatide or any of the ingredients in the formulation.
Individuals with a personal or family history of certain thyroid conditions should consult their doctor before use.
Store the injection pen according to manufacturer guidelines, usually refrigerated until use.
If severe side effects or allergic reactions occur, discontinue use and seek medical advice immediately.
Reviews
Clear filtersThere are no reviews yet.